SUN
NEUTRALSurgical Innovations Announces New Long-Term Incentive Plan
The healthcare technology company has introduced a new long-term incentive plan to align the interests of executives and employees with shareholders.
Surgical Innovations Group
0.5750GBX
0.00%
Market Cap
5.36M
Volume
32.29k
14% of avg
P/E Ratio
-28.75
EPS (TTM)
-0.02
Beta
0.28
Day Range
0.5899p - 0.5899p
52 Week Range
0.4500p0.5750p0.7500p
0.5750p
Upcoming Events
Early Q1 2026
Expected realization of cost-reduction benefits
High Impact Event
26 November 2028
End of 3-year vesting period for 2025 LTIP options
SUN
NEUTRALSurgical Innovations Announces Board Changes
The medical technology company announces changes to its Board of Directors, including the appointment of a new Non-Executive Chair and other Non-Executive Directors.
SUN
NEUTRALSurgical Innovations Reports Improved Profitability Amid Market Challenges
The medical device manufacturer reported improved profitability despite flat revenues. European growth offset challenges in other markets, while cost-reduction initiatives and new product launches aim to drive future performance.
SUN
NEUTRALSurgical Innovations Group Provides General Update
The medical device company has announced a general update, providing details on its upcoming interim results presentation.
SUN
NEUTRALSurgical Innovations Withdraws AGM Resolutions 9 and 10
The medical technology company has withdrawn two resolutions from its upcoming AGM agenda following feedback from some shareholders.
SUN
NEUTRALSurgical Innovations Group Announces AGM and Posts 2024 Annual Report
The medical technology company has announced its upcoming annual general meeting and the availability of its 2024 annual report.
SUN
BADSurgical Innovations Reports Challenging Year with Declining Profits and Margins
The medical device manufacturer faced a challenging year with declining profits and margins, despite stable revenue. Operational inefficiencies and market pressures in key regions impacted performance.
SUN
BADSurgical Innovations Group warns of lower than expected EBITDA
The medical device manufacturer warns of lower than expected profitability for the full year.
SUN
NEUTRALSurgical Innovations delays 2024 full year results
The medical device company has announced a delay in publishing its 2024 full year results, citing an orderly transition following the appointment of a new CFO.
SUN
NEUTRALSurgical Innovations Group Announces Change in Major Shareholding
The medical device manufacturer has announced a change in major shareholding, with no further details provided.